Blastomycosis Treatment Market Outlook:
Blastomycosis Treatment Market size was valued at USD 225.49 million in 2025 and is likely to cross USD 407.64 million by 2035, registering more than 6.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of blastomycosis treatment is assessed at USD 237.87 million.
The growth of the market can be attributed to the increasing cases of blastomycosis. Further, the increasing outdoor activities and poor diets across the globe are also expected to add to the market growth. For instance, the majority of blastomycosis cases are linked to exposure to soil-borne fungus in the summer. As of 2021, more than 80 cases of blastomycosis infections were reported in Minnesota.
In addition to these, factors that are believed to fuel the market growth of blastomycosis treatment include the rise in poor lifestyles. For instance, urban living contributes to dietary issues including the use of fast food and unhealthy meals, which results in a poor immune system. A weak immune system is more likely to get infected with blastomycosis and other diseases, which in turn is predicted to present the potential for market expansion over the projected period.
